Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Global Forecast 2024-2030

Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Global Forecast 2024-2030


The Self-injections Market size was estimated at USD 54.00 billion in 2023 and expected to reach USD 60.64 billion in 2024, at a CAGR 12.72% to reach USD 124.87 billion by 2030.

Self-injections refer to the products used to administer medication to themselves intramuscularly, subcutaneously, or intravenously without the immediate assistance of healthcare professionals. Self-injections are used for treatments that require regular and long-term care, such as insulin for diabetes, hormones for hormone replacement therapy and fertility treatments, and biologics for chronic conditions. Self-injection devices are widely used to increase autonomy and can improve treatment adherence by eliminating the need for healthcare provider administration. An elevating prevalence of chronic diseases, the need for home-based healthcare, advancements in drug delivery technology, and a growing patient preference for self-administration have improved the usage of self-injections in recent years. However, the requirement for significant investment in research and development, patient safety and comfort concerns, and the need for cold chain storage and logistics for biologics limit the product penetration of self-injections. Recognition of digitization and patient-centricity leads to opportunities for integrating smart technology into self-injection devices. Innovations focusing on connectivity can provide data collection, patient monitoring, and adherence tracking, guiding personalized treatment modalities for self-injections. Moreover, the supportive government approvals for self-injections are further expanding the scope of the market.

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
5.1.1.2. Wide availability of self-injections for fertility treatments
5.1.2. Restraints
5.1.2.1. Potential risk of product recall
5.1.3. Opportunities
5.1.3.1. Ongoing government approvals for self-injections worldwide
5.1.3.2. Technological advancements in self-injection devices
5.1.4. Challenges
5.1.4.1. Limited awareness and administration challenges associated with self-injections
5.2. Market Segmentation Analysis
5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
5.3. Market Trend Analysis
5.3.1. Rising incidents of diabetes and chronic diseases creating need for self-injections in the Americas
5.3.2. Growing investment in healthcare infrastructure and innovation in self-injections devices in APAC region
5.3.3. Supportive government approvals for self-injections in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors
7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Self-injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Private Clinics
9. Self-injections Market, by Therapeutic Areas Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Emergency Drugs
9.4. Hormone Replacement Therapies
10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
13.3.2. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
13.3.3. Altaviz introduces New Auto-Injector Platform For Drug Delivery
13.3.4. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
13.3.5. Civica Partners With Ypsomed For Insulin Injection Pen
13.3.6. Eitan Medical Completes Transition of Wearable Injectors Business
13.3.7. Coherus Announces U.S. Launch of UDENYCA Autoinjector
13.3.8. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
13.3.9. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
13.3.10. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
13.3.11. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SELF-INJECTIONS MARKET DYNAMICS
FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings